These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38864138)
1. [Clinicopathological characteristics of the CD8 Chai X; Sun Z; Li H; Zhu L; Liu X; Liu Y; Pei F; Chang Q Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):512-518. PubMed ID: 38864138 [TBL] [Abstract][Full Text] [Related]
2. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4 Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509 [TBL] [Abstract][Full Text] [Related]
3. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond. Karin N Front Immunol; 2020; 11():976. PubMed ID: 32547545 [TBL] [Abstract][Full Text] [Related]
4. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis. Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952 [TBL] [Abstract][Full Text] [Related]
5. Cancer-cell-secreted CXCL11 promoted CD8 Gao Q; Wang S; Chen X; Cheng S; Zhang Z; Li F; Huang L; Yang Y; Zhou B; Yue D; Wang D; Cao L; Maimela NR; Zhang B; Yu J; Wang L; Zhang Y J Immunother Cancer; 2019 Feb; 7(1):42. PubMed ID: 30744691 [TBL] [Abstract][Full Text] [Related]
6. High programmed cell death 1 ligand-1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma. Murata D; Mineharu Y; Arakawa Y; Liu B; Tanji M; Yamaguchi M; Fujimoto KI; Fukui N; Terada Y; Yokogawa R; Yamaguchi M; Minamiguchi S; Miyamoto S J Neurosurg; 2018 Mar; 128(3):710-716. PubMed ID: 28474991 [TBL] [Abstract][Full Text] [Related]
7. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres. Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222 [TBL] [Abstract][Full Text] [Related]
8. CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers. Kumaravel S; Singh S; Roy S; Venkatasamy L; White TK; Sinha S; Glaser SS; Safe SH; Chakraborty S Am J Pathol; 2020 Apr; 190(4):900-915. PubMed ID: 32035061 [TBL] [Abstract][Full Text] [Related]
9. Exercise Training Improves Tumor Control by Increasing CD8 Gomes-Santos IL; Amoozgar Z; Kumar AS; Ho WW; Roh K; Talele NP; Curtis H; Kawaguchi K; Jain RK; Fukumura D Cancer Immunol Res; 2021 Jul; 9(7):765-778. PubMed ID: 33839688 [TBL] [Abstract][Full Text] [Related]
10. CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis. Li Y; Han S; Wu B; Zhong C; Shi Y; Lv C; Fu L; Zhang Y; Lang Q; Liang Z; Yu Y; Tian Y Front Immunol; 2022; 13():951247. PubMed ID: 35935945 [TBL] [Abstract][Full Text] [Related]
11. Th17 cells inhibit CD8 Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584 [TBL] [Abstract][Full Text] [Related]
12. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer. Chen F; Yin S; Niu L; Luo J; Wang B; Xu Z; Yang G Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971 [TBL] [Abstract][Full Text] [Related]
14. LINC00152 mediates CD8 Ou J; Lei P; Yang Z; Yang M; Luo L; Mo H; Luo G; He J J Mol Histol; 2021 Jun; 52(3):611-620. PubMed ID: 33709190 [TBL] [Abstract][Full Text] [Related]
15. GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma. Ciccone R; Quintarelli C; Camera A; Pezzella M; Caruso S; Manni S; Ottaviani A; Guercio M; Del Bufalo F; Quadraccia MC; Orlando D; Di Cecca S; Sinibaldi M; Aurigemma M; Iaffaldano L; Sarcinelli A; D'Amore ML; Ceccarelli M; Nazio F; Marabitti V; Giorda E; Pezzullo M; De Stefanis C; Carai A; Rossi S; Alaggio R; Del Baldo G; Becilli M; Mastronuzzi A; De Angelis B; Locatelli F Clin Cancer Res; 2024 Jun; 30(11):2545-2557. PubMed ID: 38551501 [TBL] [Abstract][Full Text] [Related]
16. Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model. Satooka H; Ishigaki H; Todo K; Terada K; Agata Y; Itoh Y; Ogasawara K; Hirata T Sci Rep; 2020 May; 10(1):8414. PubMed ID: 32439888 [TBL] [Abstract][Full Text] [Related]
17. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis. Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210 [TBL] [Abstract][Full Text] [Related]
18. The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer. Vollmer T; Schlickeiser S; Amini L; Schulenberg S; Wendering DJ; Banday V; Jurisch A; Noster R; Kunkel D; Brindle NR; Savidis I; Akyüz L; Hecht J; Stervbo U; Roch T; Babel N; Reinke P; Winqvist O; Sherif A; Volk HD; Schmueck-Henneresse M Sci Transl Med; 2021 Jan; 13(576):. PubMed ID: 33441425 [TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy. Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704 [TBL] [Abstract][Full Text] [Related]
20. Involvement and prognosis value of CD8(+) T cells in giant cell arteritis. Samson M; Ly KH; Tournier B; Janikashvili N; Trad M; Ciudad M; Gautheron A; Devilliers H; Quipourt V; Maurier F; Meaux-Ruault N; Magy-Bertrand N; Manckoundia P; Ornetti P; Maillefert JF; Besancenot JF; Ferrand C; Mesturoux L; Labrousse F; Fauchais AL; Saas P; Martin L; Audia S; Bonnotte B J Autoimmun; 2016 Aug; 72():73-83. PubMed ID: 27236507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]